Alterations in human papillomavirus-related biomarkers after treatment of cervical intraepithelial neoplasia

Gynecologic Oncology

Volumn 121, Issue 1, 2011, Pages 43-48

  Valasoulis, G ^a   Koliopoulos, G ^a   Founta, C ^a   Kyrgiou, M ^b   Tsoumpou, I ^c   Valari, O ^a   Martin Hirsch, P ^d   Daponte, A ^e   Karakitsos, P ^f   Paraskevaidis, E ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^f NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Biomarkers; Cervical intraepithelial neoplasia (CIN); Flow cytometry; HPV DNA typing; HPV mRNA; Human papillomavirus (HPV); Loop electrosurgical excision procedure (LEEP); NASBA; p16

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16;

ACCURACY; ADULT; AGE; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CONDOM; CONTROLLED STUDY; E6 GENE; E7 GENE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; OBSERVATIONAL STUDY; PARITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEXUAL INTERCOURSE; SMOKING; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS GENE; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; ELECTROSURGERY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79952815072     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.003     Document Type: Article

References (32)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol Sep 1999;189(1):12-9. (Pubitemid 29406813)
2. Kyrgiou M, Tsoumpou I, Vrekoussis T,Martin-Hirsch P, Arbyn M, Prendiville W, et al. The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach. Cancer Treat Rev Nov 2006;32(7):516-23. (Pubitemid 44464136)
3. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000(2):CD001318.
4. Nuovo J, Melnikow J, Willan AR, Chan BK. Treatment outcomes for squamous intraepithelial lesions. Int J Gynaecol Obstet Jan 2000;68(1):25-33.
5. Martin-Hirsch PL, Koliopoulos G, Paraskevaidis E. Is it now time to evaluate the true accuracy of cervical cytology screening? A review of the literature. Eur J Gynaecol Oncol 2002;23(4):363-5. (Pubitemid 34948063)
6. Paraskevaidis E, Lolis ED, Koliopoulos G, Alamanos Y, Fotiou S, Kitchener HC. Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins. Obstet Gynecol Jun 2000;95(6 Pt 1):828-31.
7. Gardeil F, Turner MJ. A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol Nov 1997;104(11):1325 author reply 6.
8. Paraskevaidis E, Kalantaridou SN, Paschopoulos M, Zikopoulos K, Diakomanolis E, Dalkalitsis N, et al. Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 2003;24(6):541-3. (Pubitemid 37462577)
9. Sarian LO, Derchain SF, Pitta Dda R, Morais SS, Rabelo-Santos SH. Factors associated with HPV persistence after treatment for high-grade cervical intraepithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol Dec 2004;31(4):270-4. (Pubitemid 39371059)
10. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol Dec 2005;99(3 Suppl 1):S7-S11. (Pubitemid 41774340)
11. Soutter WP, de Barros Lopes A, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet Apr 5 1997;349(9057):978-80. (Pubitemid 27149800)
12. Kalliala I, Anttila A, Pukkala E, Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ Nov 19 2005;331(7526):1183-5. (Pubitemid 41689433)
13. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. In: Soutter WP, Sasieni P, Panoskaltsis T, editors. Int J Cancer Apr 15 2006.
14. Guidelines. Colposcopy and programme management. Guidelines for the NHS cervical screening programme. Second ed. NHSCSP Publication; 2010.
15. Kreimer AR, Guido RS, Solomon D, Schiffman M, Wacholder S, Jeronimo J, et al. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomark Prev May 2006;15 (5):908-14. (Pubitemid 43823517)
16. Paraskevaidis E, Arbyn M, Sotiriadis A, Diakomanolis E, Martin-Hirsch P, Koliopoulos G, et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev Apr 2004;30(2):205-11. (Pubitemid 38418058)
17. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol Jan 2007;104(1):232-46. (Pubitemid 46054137)
18. Paraskevaidis E, Koliopoulos G, Alamanos Y, Malamou-Mitsi V, Lolis ED, Kitchener HC. Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia. Obstet Gynecol Nov 2001;98(5 Pt 1):833-6. (Pubitemid 33042553)
19. Kitchener HC, Walker PG, Nelson L, Hadwin R, Patnick J, Anthony GB, et al. HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia. BJOG Jul 2008;115(8):1001-7. (Pubitemid 351841763)
20. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine Aug 31 2006;24 (Suppl 3) S3/78-89.
21. Koliopoulos G, Valasoulis G, Zilakou E. An update review on HPV testing methods for cervical neoplasia. Expert Opin Med Diagn 2009;3(2):123-31.
22. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev May 2009;35(3):210-20.
23. Valasoulis G, Tsoumpou I, Founta C, Kyrgiou M, Dalkalitsis N, Nasioutziki M, et al. The role of p16INK4a immunostaining in the risk assessment of women with LSIL cytology: a prospective pragmatic study. Eur J Gynaecol Oncol in press.
24. Kyrgiou M, Valasoulis G, Founta C, Koliopoulos G, Karakitsos P, Nasioutziki M, et al. Clinical management of HPV-related disease of the lower genital tract. Ann NY Acad Sci 2010;1205(1):57-68.
25. Paraskevaidis E, Koliopoulos G, Malamou-Mitsi V, Zikopoulos K, Paschopoulos M, Pappa L, et al. Large loop excision of the transformation zone for treating cervical intraepithelial neoplasia: a 12-year experience. Anticancer Res Jul-Aug 2001;21 (4B):3097-9. (Pubitemid 33051182)
26. Paraskevaidis E, Koliopoulos G, Paschopoulos M, Stefanidis K, Navrozoglou I, Lolis D. Effects of ball cauterization following loop excision and follow-up colposcopy. Obstet Gynecol Apr 2001;97(4):617-20.
27. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis Nov 2002;29(11):725-35. (Pubitemid 35266418)
28. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med Jun 22 2006;354(25):2645-54.
29. Vaccarella S, Franceschi S, Herrero R, Munoz N, Snijders PJ, Clifford GM, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomark Prev Feb 2006;15(2):326-33. (Pubitemid 43342183)
30. Oral communication - effect of condom use after CIN treatment on HPV positivity and other biomarkers: a randomised controlled trial. In: Kyrgiou M, Valasoulis G, Karakitsos P, Founta C, Arbyn M, Koliopoulos G, et al, editors. 26th International Papillomavirus Conference; 2010. Montreal, Canada.
31. Oral presentation - management of women with low-grade cytological abnormalities: a comparison of triage options. In: Tsoumpou I, Founta C, Karakitsos P, Kyrgiou M, Valasoulis G, Arbyn M, et al, editors. Annual scientific meeting of the BSCCP 2010; 2010. Brighton, UK.
32. Oral presentation - management of women with high-grade cytological abnormalities: a comparison of triage options. In: Kyrgiou M, Gritzeli S, Valasoulis G, Founta C, Karakitsos P, Arbyn M, et al, editors. Annual scientific meeting of the BSCCP 2010; 2010. Brighton, UK.